NCT01356758 Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents Status COMPLETED Phase N/A
NCT01356004 Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis Status COMPLETED Phase PHASE4
NCT01352780 Psoriasis and Climate Therapy- Effect of Motivational Follow- up Calls on Clinical and Health Economic Parameters Status UNKNOWN Phase PHASE3
NCT01328366 Quality of Life and Psychosocial Factors Associated With Severe Psoriasis Following Treatment With Adalimumab Status COMPLETED Phase N/A
NCT01320293 Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab. Status COMPLETED Phase NA
NCT01316224 Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment Status COMPLETED Phase N/A
NCT01313221 Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01309737 A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01300052 AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis Status COMPLETED Phase PHASE2
NCT01283698 Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis Status COMPLETED Phase PHASE2
NCT01276847 A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206) Status COMPLETED Phase PHASE1
NCT01276639 A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01265823 Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT01262534 A Study to Assess the Clinical Profile of Patients in Spain With Moderate to Severe Psoriasis. Status COMPLETED Phase N/A
NCT01261767 First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects Status TERMINATED Phase PHASE1
NCT01254240 Efficacy Study of Two Choices of Phototherapy on Itching Skin Diseases Status COMPLETED Phase PHASE2
NCT01245140 Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis Status COMPLETED Phase PHASE2
NCT01241591 A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3